Table 2.

Differences in clinical presentation between patients receiving no or currently recommended immunosuppressive therapy during follow-up

Control GroupTreatment GroupP
n13257
Patients per era (era 1, 2, 3, respectively)47, 66, 196, 34, 17
At presentation
    female gender (%)40250.04
    age47 ± 1649 ± 14>0.1
    CrCl (ml/min per 1.73 m2)81 ± 3174 ± 24>0.1
    MAP (mmHg)101 ± 13103 ± 12>0.1
    proteinuria (g/d)
        initial4.9 (2.9 to 8.6)8.8 (5.2 to 11.5)<0.01
        peak6.4 (4.0 to 10.0)13.3 (10.8 to 20.5)<0.01
    number of antihypertensive drugs0 (0 to 1)0 (0 to 1)
  • CrCl, Creatinine clearance; MAP, mean arterial pressure.